PERK/ATF4/CHOP activates GOLGA2P10 and modulates the activity of bcl-2, a regulator of apoptosis, and exerts a protective effect for the tumor cells and thus can act as the target for anticancer therapy [50]. This evidence concerns the gene DDIT3 and neoplasm.